| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/17425255.2011.547473 |
| P8608 | Fatcat ID | release_pdhygi2r4zdetjg4cgjddoibbm |
| P698 | PubMed publication ID | 21219245 |
| P2093 | author name string | Richard H Barton | |
| P2860 | cites work | HMDB: a knowledgebase for the human metabolome | Q24655295 |
| MetaboAnalyst: a web server for metabolomic data analysis and interpretation | Q24655530 | ||
| The Chemical Translation Service--a web-based tool to improve standardization of metabolomic reports | Q27062596 | ||
| Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research | Q29014502 | ||
| 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data | Q29784220 | ||
| Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma | Q30475550 | ||
| Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets | Q30983576 | ||
| Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies | Q31029583 | ||
| Two-dimensional correlation analysis of nuclear magnetic resonance metabonomics data | Q31171632 | ||
| Pattern recognition analysis of high resolution 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data | Q34070223 | ||
| Metabonomics: a platform for studying drug toxicity and gene function | Q34139125 | ||
| Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts | Q34714204 | ||
| Human metabolic phenotype diversity and its association with diet and blood pressure. | Q34772005 | ||
| Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice | Q35033766 | ||
| Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes | Q36013427 | ||
| Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism | Q37318311 | ||
| Long-lived states to sustain hyperpolarized magnetization. | Q37413544 | ||
| The evolution of metabolic profiling in parasitology | Q37742204 | ||
| Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice | Q40223413 | ||
| Metabolite identification using a nanoelectrospray LC-EC-array-MS integrated system | Q43160990 | ||
| The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies | Q43213966 | ||
| Application of orthogonal signal correction to minimise the effects of physical and biological variation in high resolution 1H NMR spectra of biofluids | Q44215537 | ||
| Supervised self organizing maps for classification and determination of potentially discriminatory variables: illustrated by application to nuclear magnetic resonance metabolomic profiling | Q44770151 | ||
| Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles | Q44896606 | ||
| Evaluation of full-resolution J-resolved 1H NMR projections of biofluids for metabonomics information retrieval and biomarker identification | Q45162117 | ||
| Statistical total correlation spectroscopy editing of 1H NMR spectra of biofluids: application to drug metabolite profile identification and enhanced information recovery. | Q45938448 | ||
| Web server based complex mixture analysis by NMR. | Q46059126 | ||
| Application of a 1H nuclear magnetic resonance (NMR) metabolomics approach combined with orthogonal projections to latent structure-discriminant analysis as an efficient tool for discriminating between Korean and Chinese herbal medicines | Q46216521 | ||
| Quantitative monitoring of extracellular matrix production in bone implants by 13C and 31P solid-state nuclear magnetic resonance spectroscopy. | Q51033570 | ||
| Two-dimensional statistical recoupling for the identification of perturbed metabolic networks from NMR spectroscopy. | Q52601742 | ||
| MI-Pack: Increased confidence of metabolite identification in mass spectra by integrating accurate masses and metabolic pathways | Q57803311 | ||
| Intra- and inter-omic fusion of metabolic profiling data in a systems biology framework | Q58045659 | ||
| Metabonomic Studies on the Physiological Effects of Acute and Chronic Psychological Stress in Sprague−Dawley Rats | Q58045862 | ||
| Batch statistical processing of1H NMR-derived urinary spectral data | Q58046075 | ||
| Detection ofin vivo biomarkers of phospholipidosis using NMR-based metabonomic approaches | Q58046137 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 129-136 | |
| P577 | publication date | 2011-01-10 | |
| P1433 | published in | Expert Opinion on Drug Metabolism & Toxicology | Q5421205 |
| P1476 | title | A decade of advances in metabonomics | |
| P478 | volume | 7 |
| Q62020441 | Accelerating Metabolite Identification in Natural Product Research: Toward an Ideal Combination of Liquid Chromatography–High-Resolution Tandem Mass Spectrometry and NMR Profiling, in Silico Databases, and Chemometrics |
| Q30607142 | An automated Pearson's correlation change classification (APC3) approach for GC/MS metabonomic data using total ion chromatograms (TICs). |
| Q37862739 | Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity |
| Q38126853 | Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches |
| Q37484601 | Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma |
| Q34444673 | NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review |
| Q36589155 | Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling |
Search more.